Kingdon Capital Management L.L.C. Acquires Shares of 45,128 Humana Inc. (HUM)
Kingdon Capital Management L.L.C. acquired a new stake in Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 45,128 shares of the insurance provider’s stock, valued at approximately $10,859,000.
Other institutional investors have also added to or reduced their stakes in the company. Guardian Life Insurance Co. of America lifted its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares in the last quarter. Acrospire Investment Management LLC bought a new position in shares of Humana during the second quarter valued at about $120,000. Independent Portfolio Consultants Inc. lifted its position in shares of Humana by 22.1% during the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after purchasing an additional 94 shares in the last quarter. Point72 Asia Hong Kong Ltd bought a new position in shares of Humana during the first quarter valued at about $128,000. Finally, Northwestern Mutual Wealth Management Co. lifted its position in shares of Humana by 139.5% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock valued at $134,000 after purchasing an additional 325 shares in the last quarter. 95.12% of the stock is currently owned by hedge funds and other institutional investors.
In related news, insider Elizabeth D. Bierbower sold 9,786 shares of the stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $259.00, for a total value of $2,534,574.00. Following the completion of the sale, the insider now directly owns 18,042 shares of the company’s stock, valued at approximately $4,672,878. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP M Todoroff Christopher sold 22,935 shares of the stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $252.52, for a total transaction of $5,791,546.20. Following the completion of the sale, the vice president now directly owns 24,001 shares of the company’s stock, valued at $6,060,732.52. The disclosure for this sale can be found here. Insiders sold a total of 55,595 shares of company stock valued at $14,133,706 over the last three months. 0.80% of the stock is currently owned by insiders.
A number of research analysts recently weighed in on HUM shares. Argus raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a research report on Friday, June 9th. Piper Jaffray Companies reissued a “buy” rating and set a $246.00 price target on shares of Humana in a research report on Friday, July 14th. Cowen and Company reissued a “buy” rating and set a $230.00 price target on shares of Humana in a research report on Friday, July 14th. Bank of America Corporation raised their price target on shares of Humana from $270.00 to $275.00 and gave the company a “buy” rating in a research report on Friday, July 14th. Finally, Citigroup Inc. started coverage on shares of Humana in a research report on Wednesday, June 28th. They set a “buy” rating and a $275.00 price target on the stock. Nine analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $247.50.
Humana Inc. (NYSE HUM) traded up 0.764% during trading on Friday, hitting $247.235. 286,223 shares of the stock traded hands. Humana Inc. has a 52-week low of $163.50 and a 52-week high of $259.76. The company has a market cap of $35.73 billion, a P/E ratio of 20.339 and a beta of 0.86. The firm has a 50-day moving average price of $249.11 and a 200 day moving average price of $234.09.
Humana (NYSE:HUM) last released its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The company had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same period in the prior year, the firm posted $2.30 EPS. On average, equities analysts expect that Humana Inc. will post $11.55 EPS for the current year.
The company also recently announced a dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 29th will be issued a $0.40 dividend. The ex-dividend date is Thursday, September 28th. Humana’s dividend payout ratio is 13.06%.
TRADEMARK VIOLATION NOTICE: This piece of content was published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/kingdon-capital-management-l-l-c-acquires-shares-of-45128-humana-inc-hum/1612859.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.